BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34657827)

  • 1. Relevance of early diagnosis in polycythemia vera and essential thrombocythemia: A single center's experience.
    Lakhwani S; Pardina-Echevarría M; Arcas-Vega R; Díaz-Sánchez OR; Hernández-García MT; Raya JM
    Rev Clin Esp (Barc); 2022 Mar; 222(3):169-173. PubMed ID: 34657827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A; Barbui T
    Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management strategies for polycythemia vera and essential thrombocythemia.
    Guglielmelli P; Vannucchi AM
    Blood Rev; 2020 Jul; 42():100714. PubMed ID: 32546373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State-of-the-art management for essential thrombocythemia and polycythemia vera].
    Sugimoto Y
    Rinsho Ketsueki; 2021; 62(8):1050-1059. PubMed ID: 34497191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2020 Dec; 95(12):1599-1613. PubMed ID: 32974939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of thrombosis in essential thrombocythemia and polycythemia vera.
    Pearson TC
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):16-21. PubMed ID: 12096353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary approach to essential thrombocythemia and polycythemia vera.
    Aruch D; Mascarenhas J
    Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.
    Ianotto JC; Curto-Garcia N; Lauermanova M; Radia D; Kiladjian JJ; Harrison CN
    Haematologica; 2019 Aug; 104(8):1580-1588. PubMed ID: 30679326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia.
    Grenier JMP; El Nemer W; De Grandis M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis.
    Iland HJ; Laszlo J; Case DC; Murphy S; Reichert TA; Tso CY; Wasserman LR
    Am J Hematol; 1987 Jun; 25(2):191-201. PubMed ID: 3605067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.
    Schafer AI
    Blood; 2006 Jun; 107(11):4214-22. PubMed ID: 16484586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
    Thiele J; Kvasnicka HM; Diehl V
    Acta Haematol; 2005; 113(4):213-9. PubMed ID: 15983426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
    Hernández-Boluda JC; Gómez M
    Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.